Sun Opthalmics

72 no way . Most people interviewing have some exsperience. I make in the 90’s at my current job and have been in industry 16 years.

 

16 years and you’re only making $90K. You sound like the perfect, pathetic piss poor rep then for Sun. You’re never getting $90 at this shit hole. Oh wait, you might! They’re total dipshits.

 

You are an ass.

 

Leave the Queen Z out of this.

 

Nah.
Only because there’s three very different sides - what we see from when she’s in the front of the room (glowing BS about the company) what she says in front of her select team members (bitchin’), and what she says in front of Ahbay (who she can’t stand).
Have the guts to take a single position and stick to it.

 

90's with 16yrs exp? That's peanuts!

 

Peanuts? It's laughable! What a shit rep!

 

No buddy I think you're the shit rep! If ur making only 90's and have been in the industry for 16yrs ur clearly the shittiesttt rep in America LMAO.. U either suck at what you do or a complete idiot LOL

 

It’s this kind of banter, between current and/or prospective Sun employees, that confirms this company’s complete lack of ability to attract people with talent.

It’s the bottom-of-the-barrel dregs that are at (or who are applying at) Sun. So if that’s who you are, then Sun is where you should be.

#attentionWalmartshoppers

 

I would like to thank Sun Pharma OBU for “creating” Xelpros. It has been a long long time since I laughed that hard. You have managed to take generic latanaprost , once daily, 6-8mm reduction in iop, negligible AE profile and around $5-$10 and develop a ......wait for it............. once daily, 6-8mm reduction in iop, ~50% AE profile with a branded price $$$.
Bravo to you. You’ve done it again.... oh yeah, it is BAK free...Maybe you can get a portion of all that Zioptan business that is out there.......

 

Spot on! How dumb are these guys!

 

They are smelly indians...what do you expect? They think everyone else is stupid. They are losing millions of dollars in US business. My guess is within 3 years they pull put of US completely due to strain on worldwide budget.

 

I doubt it goes 3 years. Bromsite has a 15% market share. The dry eye might do well if its covered but the glaucoma drug is ridiculous. AGN's Lumigan time release/implant will own the market. Me too drugs are impossible to sell.

 

Hey sh**bird. You have no idea what you are talking about and show your complete ignorance! I know for a fact she likes what she does, loves her team and enjoys who she is working for. She’s here because she chooses to and wants to make a difference. Go spew your vomit elsewhere! Get a life.

 

You don’t have a clue! If you are not happy get out! You bad mouth people anonymously because if people knew who you were you would be slammed. Say what you want about Sun’s worts -every company has them. Some of us enjoy our jobs and who we work with! I do my job and get paid well. Maybe you should try it- moron.

 

A branded cyclosporine with a generic cyclosporine around the corner? In this industry where all new drugs need a year to even get decent coverage good luck. Well it does have a novel delivery system. Great, can hear the plans now......has thw patient failed on restais and xiidra first?

 

So what are you saying, not even 3 years and this all folds?

 

What's the deal with the Ophthalmics in northern VA? Position keeps gettin posted. New territory or reps jumping ship?

Hows the DM to work w? In a bind.. any serious replies appreciated!

 

Most ophth drugs are somehow connected to a sugical ophthalmology practice. Prescribing expensive Rx topicals takes money out of the practice and gets patients pissed that their "drops" are expensive. Ophth practices will use the implants because they work better and are chairside procedures...more money in the doc pocket. Low rent patients will stick with topicals, but not want to pay for innovation (large or small). SUN is low rent and fits into that space. Small innovation technology to old established topical medications that patients and managed care will not apreciate.